Suppr超能文献

人工智能在个性化视网膜疾病管理中的应用

Artificial intelligence in individualized retinal disease management.

作者信息

Zhang Zi-Ran, Li Jia-Jun, Li Ke-Ran

机构信息

The Affiliated Eye Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.

Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.

出版信息

Int J Ophthalmol. 2024 Aug 18;17(8):1519-1530. doi: 10.18240/ijo.2024.08.19. eCollection 2024.

Abstract

Owing to the rapid development of modern computer technologies, artificial intelligence (AI) has emerged as an essential instrument for intelligent analysis across a range of fields. AI has been proven to be highly effective in ophthalmology, where it is frequently used for identifying, diagnosing, and typing retinal diseases. An increasing number of researchers have begun to comprehensively map patients' retinal diseases using AI, which has made individualized clinical prediction and treatment possible. These include prognostic improvement, risk prediction, progression assessment, and interventional therapies for retinal diseases. Researchers have used a range of input data methods to increase the accuracy and dependability of the results, including the use of tabular, textual, or image-based input data. They also combined the analyses of multiple types of input data. To give ophthalmologists access to precise, individualized, and high-quality treatment strategies that will further optimize treatment outcomes, this review summarizes the latest findings in AI research related to the prediction and guidance of clinical diagnosis and treatment of retinal diseases.

摘要

由于现代计算机技术的快速发展,人工智能(AI)已成为跨领域智能分析的重要工具。人工智能在眼科领域已被证明非常有效,常用于识别、诊断和分类视网膜疾病。越来越多的研究人员开始使用人工智能全面绘制患者的视网膜疾病图谱,这使得个性化的临床预测和治疗成为可能。这些包括视网膜疾病的预后改善、风险预测、病情进展评估和介入治疗。研究人员使用了一系列输入数据方法来提高结果的准确性和可靠性,包括使用表格、文本或基于图像的输入数据。他们还结合了多种类型输入数据的分析。为了让眼科医生能够获得精确、个性化和高质量的治疗策略,从而进一步优化治疗效果,本综述总结了人工智能研究中与视网膜疾病临床诊断和治疗的预测及指导相关的最新发现。

相似文献

1
Artificial intelligence in individualized retinal disease management.人工智能在个性化视网膜疾病管理中的应用
Int J Ophthalmol. 2024 Aug 18;17(8):1519-1530. doi: 10.18240/ijo.2024.08.19. eCollection 2024.
5
Artificial intelligence in retinal imaging: current status and future prospects.视网膜成像中的人工智能:现状与未来展望。
Expert Rev Med Devices. 2024 Jan-Feb;21(1-2):73-89. doi: 10.1080/17434440.2023.2294364. Epub 2024 Feb 4.
9

本文引用的文献

2
Investigational drugs inhibiting complement for the treatment of geographic atrophy.用于治疗地图状萎缩的抑制补体的研究性药物。
Expert Opin Investig Drugs. 2023 Jul-Dec;32(11):1009-1016. doi: 10.1080/13543784.2023.2276759. Epub 2023 Nov 24.
3
Artificial intelligence in ophthalmology.人工智能在眼科学中的应用。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):207-213. doi: 10.22336/rjo.2023.37.
7
Artificial intelligence in ophthalmology.眼科中的人工智能
Int J Ophthalmol. 2023 Sep 18;16(9):1357-1360. doi: 10.18240/ijo.2023.09.01. eCollection 2023.
8
Current Treatments for Diabetic Macular Edema.糖尿病性黄斑水肿的当前治疗方法。
Int J Mol Sci. 2023 May 31;24(11):9591. doi: 10.3390/ijms24119591.
9
Meta-Analyses of Two Treatment Regimens for Retinal Vein Occlusion.视网膜静脉阻塞两种治疗方案的Meta分析
Ophthalmic Surg Lasers Imaging Retina. 2023 Apr;54(4):244-250. doi: 10.3928/23258160-20230320-01. Epub 2023 Apr 1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验